Is There a Need for an Exogenous Activator Along with PRP for Early Knee Osteoarthritis? A Triple-Blinded Randomized Control Trial
In brief
This triple-blinded randomised trial asked whether adding calcium gluconate as an activator changes the effect of platelet-rich plasma (PRP) in early knee osteoarthritis. Pain, function and satisfaction improved similarly in both groups over several months, and the authors conclude that the value of adding an external activator is doubtful.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Is There a Need for an Exogenous Activator Along with PRP for Early Knee Osteoarthritis? A Triple-Blinded Randomized Control Trial Authors: Shivam Rai, Sandeep Patel, Devendra Kumar Chouhan, Ashish Jain, Tarkik Thami, Ankit Dadra & Mandeep Singh Dhillon Link: https://pubmed.ncbi.nlm.nih.gov/38948365/ Year of Publication: 2024
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

